Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Trading Report for (STJ). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Market Edge
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
St. Jude Medical Inc Issues Q3 2012 EPS Guidance; Lowers FY 2012 EPS Guidance
St. Jude Medical Inc announced that it expects its consolidated adjusted net earnings for the third quarter of 2012 to be in the range of $0.80 to $0.82 per diluted share and for fiscal 2012 consolidated adjusted net earnings to now be in the range of $3.40 to $3.45. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $0.83 for third quarter of 2012 and EPS of $3.46 for fiscal 2012.
Latest Developments for St. Jude Medical Inc
- St. Jude Medical Inc Issues Q2 2013 EPS Guidance In Line With Analysts' Estimates; Reaffirms FY 2013 EPS Guidance
- St. Jude Medical Inc Receives CE Mark Approval Of Deep Brain Stimulation Systems For Both Primary And Secondary Dystonia
- St. Jude Medical Inc Announces Public Offering of Senior Notes
- St. Jude Medical Inc Recalls Wire Used To Help Plug Hole In Heart-Reuters
- Share this
- Link this
- Digg this
Follow Reuters